Israel's Pluristem sees positive results from leg pain study
TEL AVIV (Reuters) - Israel's Pluristem Therapeutics Inc, a developer of placenta-based stem cell products, said on Tuesday it had positive results from a mid-stage study of its therapy to treat leg pain known as intermittent claudication (IC).
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Health | Intermittent Claudication | Israel Health | Middle East Health | Pain | Stem Cell Therapy | Stem Cells | Study